Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:51 pm Purchase |
2024-12-31 | 13G | Moleculin Biotech, Inc. MBRX |
Armistice Capital, LLC | 339,767 9.990% |
38,779 (+12.88%) |
Filing History |
| 2024-11-14 5:12 pm Purchase |
2024-09-30 | 13G | Moleculin Biotech, Inc. MBRX |
Armistice Capital, LLC | 300,988 9.990% |
300,988 (New Position) |
Filing History |
| 2024-02-14 3:43 pm Purchase |
2023-12-31 | 13G | Moleculin Biotech, Inc. MBRX |
Armistice Capital, LLC | 221,081 9.990% |
221,081 (New Position) |
Filing History |
| 2021-02-10 11:28 am Purchase |
2020-12-31 | 13G | Moleculin Biotech, Inc. MBRX |
The Vanguard Group | 39,464 0.950% |
10,551 (+36.49%) |
Filing History |
| 2021-01-20 11:14 am Sale |
2020-12-31 | 13G | Moleculin Biotech, Inc. MBRX |
Empery Asset Management, LP | 33,223 4.570% |
-8,444 (-20.27%) |
Filing History |
| 2021-01-04 2:02 pm Sale |
2020-12-31 | 13G | Moleculin Biotech, Inc. MBRX |
SABBY MANAGEMENT LLC | 34,633 11.000% |
-7,034 (-16.88%) |
Filing History |
| 2020-11-13 06:01 am Purchase |
2020-11-12 | 13G | Moleculin Biotech, Inc. MBRX |
Lincoln Park Capital Fund LLC | 53,192 7.520% |
53,192 (New Position) |
Filing History |